Carcinoid Syndrome & Term Life Insurance (2026)

Getting Term Life Insurance With Carcinoid Syndrome

A carcinoid syndrome diagnosis changes a lot of things. But your ability to get term life insurance isn’t one of them. You may pay more than someone without the condition, and some carriers will be more favorable than others. The good news is that coverage is absolutely available, and the rate you pay depends heavily on where you apply.

Insurance By Heroes was founded by a former first responder and military spouse. Our team comes from public service backgrounds, including military, law enforcement, fire, EMS, and healthcare. That matters here because we understand what it feels like to face a system that seems stacked against you. We’re also an independent agency, which means we aren’t locked into selling one company’s products. We work with dozens of carriers, and that gives us the ability to shop your case to find the most competitive rate. For a condition like carcinoid syndrome, that difference can be significant.

If you’ve already been turned down by one company or received a quote that made your stomach drop, don’t assume that’s the final answer. It’s probably not. Different carriers look at carcinoid syndrome very differently, and the rate gap between them can be surprisingly wide.

Why Carcinoid Syndrome Affects Your Rates

Underwriters assess risk based on statistics. Carcinoid syndrome involves neuroendocrine tumors that release hormones like serotonin into the bloodstream, causing symptoms like flushing, diarrhea, and in some cases heart valve complications. From an underwriting perspective, the concern centers on tumor behavior, how well symptoms are managed, and whether the condition has affected organ function, particularly the heart.

That said, many people with carcinoid syndrome live for years or even decades with well managed disease. Underwriters know this. They’re not automatically declining these applications. They’re rating them based on the specifics of your case.

What Underwriters Actually Evaluate

Every carrier has its own checklist, but most underwriters focus on a handful of key factors when reviewing a carcinoid syndrome application.

The date of your diagnosis matters. The longer you’ve had a stable, managed condition, the better your classification is likely to be. A diagnosis from five years ago with consistent treatment and no progression tells a very different story than a recent one.

Tumor location and whether it has metastasized is the biggest factor. Primary tumors confined to the gastrointestinal tract with no spread carry much better odds than metastatic disease. If your oncologist has documented stable imaging over the past one to two years, that’s exactly what underwriters want to see.

Cardiac involvement changes the picture significantly. Carcinoid heart disease, where serotonin damages heart valves, moves you into a harder underwriting category. If echocardiograms show no valve issues, make sure that documentation is front and center in your application.

Current treatment is also evaluated. Are you on somatostatin analogs like octreotide? Is the treatment controlling symptoms effectively? Stable, well managed cases get the best available ratings.

Your 5 HIAA levels (a urine test measuring serotonin metabolites) and chromogranin A levels give underwriters a snapshot of tumor activity. Lower, stable levels work in your favor.

How Table Ratings Work in Real Dollars

Most people with carcinoid syndrome will receive a table rating rather than a standard rate. Here’s what that actually means in plain terms.

Table 1 adds roughly 25% above standard rates. Table 2 adds about 50%. Table 4 doubles the standard premium. Table 6 adds 150%. The tables go up to 8 or sometimes higher.

To put that in perspective, a 40 year old applying for a $500,000 twenty year term policy might pay around $45 to $65 per month at standard rates. At Table 2, that becomes roughly $65 to $90 per month. At Table 4, you’re looking at $90 to $130. That Table 4 rate is still less than what many people spend on their phone bill and streaming subscriptions combined.

The critical thing to understand is that the same person with the same medical records can be rated Table 2 at one carrier and Table 4 or even Table 6 at another. That’s not a small difference. Over a 20 year term, two tables apart on a $500,000 policy can mean thousands of dollars.

Why the Carrier You Apply With Matters So Much

This is where most people make a costly mistake. They apply with one company, usually whatever pops up first online or whoever their friend uses, get a table rating or decline, and assume that’s the answer everywhere.

It’s not. Each insurance carrier has its own underwriting guidelines, its own medical directors, and its own appetite for risk. Some carriers have carved out favorable niches for neuroendocrine conditions. Others barely touch them. One carrier’s automatic decline is another carrier’s Table 2.

This is exactly why working with an independent agency changes the outcome. A captive agent at a single company has one set of guidelines to work with. If their company rates carcinoid syndrome at Table 6, that’s what you get. An independent agency like Insurance By Heroes can submit your case to dozens of carriers, compare their responses, and place you with the one that offers the best classification.

Every carrier weighs these factors differently, which is why comparing quotes is so valuable. The best way to know your actual rate is to get personalized quotes based on your specific situation. You can click the quote button on any page to start that process. A real person reviews your information, not an algorithm.

Positioning Yourself for the Best Rating

Before you apply, take a few steps that can meaningfully improve your outcome.

Gather your medical records. You want at least two years of oncology reports showing stable disease, recent imaging (CT or MRI), lab results including 5 HIAA and chromogranin A levels, and a recent echocardiogram showing no cardiac involvement. The more documentation you have showing stability, the stronger your application.

Get a letter from your oncologist. A brief statement confirming that your condition is stable, symptoms are well controlled, and there’s no evidence of progression carries real weight with underwriters. Not every agent will tell you to do this. But it can make the difference between Table 4 and Table 2.

Don’t hide anything. Some applicants downplay their condition hoping for a better rate. This backfires almost every time. Underwriters will pull your medical records through the MIB and prescription databases. Inconsistencies raise red flags and can lead to a worse rating or a decline that would not have happened otherwise.

Consider your term length carefully. A 10 or 15 year term may be easier to qualify for than a 30 year term, especially if your diagnosis is relatively recent. Many term policies include a conversion option, which lets you convert to permanent coverage later without going through medical underwriting again. That’s a powerful safety net.

Mistakes That Cost You Money

Applying to the wrong carrier first creates an MIB record of your application and any adverse decisions. While this doesn’t doom future applications, it does create a paper trail. Working with an experienced independent agent who knows which carriers are favorable for carcinoid cases means your first application goes to the right place.

Waiting for “better health” before applying is another common mistake. Every birthday increases your base premium regardless of your health. And carcinoid syndrome, while often manageable, can develop complications over time. If your condition is stable now, that stability is your best asset. Lock it in. Today’s health becomes tomorrow’s locked in price, and that math doesn’t change.

Relying solely on employer group life insurance is risky too. Most group policies cover one to two times your salary, which usually falls far short of what your family actually needs. And if you leave that job, the coverage disappears. You’ll be older, possibly with a more complex medical history, and facing much higher individual rates. A personal term policy that you own and control fills that gap.

Getting quotes is free and gives you real numbers instead of guesswork. When you’re ready to see what you’d actually pay, the quote button on this page connects you with our team directly. No call center. No pressure.

Frequently Asked Questions

How much more does term life insurance cost with carcinoid syndrome?

Most applicants with stable carcinoid syndrome can expect a table rating, which typically adds 25% to 100% above standard rates depending on the carrier and specifics of your case. For a 40 year old buying $500,000 of 20 year coverage, that might mean paying $65 to $130 per month instead of $45 to $65. Shopping across multiple carriers often brings that number down because different companies rate this condition very differently.

Can I get approved for term life insurance with carcinoid syndrome?

Yes. Many carriers will approve applicants with carcinoid syndrome, especially those with stable, well managed disease and no cardiac involvement. A recent decline from one company does not mean you’ll be declined everywhere. An independent agent can identify which carriers are most favorable for your specific situation.

What medical records should I have ready before applying?

Gather your most recent oncology reports, imaging results (CT or MRI) from the past 12 months, lab work including 5 HIAA and chromogranin A levels, and a current echocardiogram. A brief letter from your oncologist confirming stable disease can also strengthen your application significantly.

Should I choose a shorter or longer term if I have carcinoid syndrome?

Shorter terms (10 or 15 years) are generally easier to qualify for and may receive more favorable ratings. If your coverage needs extend further, look for a policy with a conversion option. This allows you to convert to permanent coverage down the road without new medical underwriting, giving you flexibility as your health and financial picture evolve.